Edinburgh Research Explorer

Loss of zfp36 expression in colorectal cancer correlates to wnt/ ß-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of zeb1, sox9 and macc1

Research output: Contribution to journalArticle

  • Lucia Montorsi
  • Filippo Guizzetti
  • Claudia Alecci
  • Andrea Caporali
  • Andrea Martello
  • Claudio Giacinto Atene
  • Sandra Parenti
  • Silvia Pizzini
  • Paola Zanovello
  • Stefania Bortoluzzi
  • Sergio Ferrari
  • Alexis Grande
  • Tommaso Zanocco-Marani

Related Edinburgh Organisations

Open Access permissions

Open

Documents

  • Download as Adobe PDF

    Rights statement: All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License. PII: 10828

    Final published version, 9.52 MB, PDF document

    Licence: Creative Commons: Attribution (CC-BY)

Original languageEnglish
JournalOncotarget
DOIs
Publication statusPublished - 24 Jul 2016

Abstract

The mRNA-destabilizing protein ZFP36 has been previously described as a tumor suppressor whose expression is lost during colorectal cancer development. In order to evaluate its role in this disease, we restored ZFP36 expression in different cell contexts, showing that the presence of this protein impairs the epithelial-to-mesenchymal transition (EMT) and induces a higher susceptibility to anoikis. Consistently, we found that ZFP36 inhibits the expression of three key transcription factors involved in EMT: ZEB1, MACC1 and SOX9. Finally, we observed for the first time that its expression negatively correlates with the activity of Wnt/β-catenin pathway, which is constitutively activated in colorectal cancer. This evidence provides a clue on the mechanism leading to the loss of ZFP36 in CRC.

Download statistics

No data available

ID: 27396860